Pharmacogenomics of Drug Safety in Multiple Sclerosis

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Multiple Sclerosis
Trial Locations (5)

V6T 2B5

RECRUITING

MS Clinic UBC Hospital, Vancouver

Unknown

COMPLETED

Winnipeg Health Sciences Centre, Winnipeg

ENROLLING_BY_INVITATION

Dalhousie MS Research Unit, Halifax

ENROLLING_BY_INVITATION

London Health Sciences Centre MS clinic, London

ENROLLING_BY_INVITATION

Hôpital Notre-Dame MS clinic, Montreal

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Canada Foundation for Innovation

OTHER

collaborator

Genome Canada

OTHER

collaborator

British Columbia Clinical Genomics Network

OTHER

lead

University of British Columbia

OTHER

NCT01118130 - Pharmacogenomics of Drug Safety in Multiple Sclerosis | Biotech Hunter | Biotech Hunter